MV
Morningside Venture Investments
Venture CapitalActiveMorningside Venture Investments is an investment group that provides industry investments and social responsibility.
17
Investments
10
Exits
$1.7B
AUM
58.8%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Morningside Venture Investments.
Investment Thesis & Strategy
Morningside Venture Investments invests in various stages across a broad range of industries, seeking companies with a focus on social responsibility.
Investment Activity
Deals per year over the last 8 years
1
20102
20110
20122
20132
20142
20152
20161
2017Portfolio Companies
Selected investments from their portfolio of 17 companies
A
Adagene
Biotech · Growth, 2017
A
Apollomics
Biotech · Growth, 2016
H
Harbour BioMed
Biotech · Growth, 2016
i
iCarbonX
Healthcare · Series A, 2015
X
XtalPi
Biotech · Series C+, 2015
G
Ginkgo Bioworks
Biotech · Growth, 2014
I
Insilico Medicine
Biotech · Series C+, 2014
Z
Zai Lab
Biotech · Growth, 2013
B
Biohaven Pharmaceutical
Biotech · Growth, 2013
I
Innovent Biologics
Biotech · Growth, 2011
I
Innovent Biologics
Biotech · Growth, 2011
B
BeiGene
Biotech · Growth, 2010
Notable Exits
CompanyTypeYearValue / Acquirer
XtalPiAcquisition2024—
Gan & Lee PharmaceuticalsIPO2021—
Harbour BioMedIPO2020—
WuXi AppTecIPO2018$8.5B
Innovent BiologicsIPO2018$3.3B
Zai LabIPO2017—
Celltrion HealthcareIPO2017—
CelltrionIPO2017—
BeiGeneIPO2016—
3SBioIPO2009—
Frequently Asked Questions
Morningside Venture Investments focuses on Series A, Series B, Series C+ stage investments.